We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI Poised to Transform Outcomes in Cardiovascular Health Care

By HospiMedica International staff writers
Posted on 18 Jul 2022
Print article
Image: A new collaboration will advance cardiac health through AI (Photo courtesy of Unsplash)
Image: A new collaboration will advance cardiac health through AI (Photo courtesy of Unsplash)

Employing artificial intelligence (AI) to help improve outcomes for people with cardiovascular disease is the focus of a three-year, USD 15 million collaboration between world-leading experts in machine learning and AI, and outstanding cardiologists and clinicians. The Cardiovascular AI Initiative aims to improve heart failure treatment, as well as predict and prevent heart failure.

Researchers from Cornell University (Ithaca, NY, USA) along with physicians from NewYork-Presbyterian (New York, NY, USA) will use AI and machine learning to examine data from NewYork-Presbyterian in an effort to detect patterns that will help physicians predict who will develop heart failure, inform care decisions and tailor treatments for their patients. The Cardiovascular AI Initiative will develop advanced machine-learning techniques to learn and discover interactions across a broad range of cardiac signals, with the goal of providing improved recognition accuracy of heart failure and extend the state of care beyond current, codified and clinical decision-making rules. It will also use AI techniques to analyze raw data from time series (EKG) and imaging data.

Researchers and clinicians anticipate the data will help answer questions around heart failure prediction, diagnosis, prognosis, risk and treatment, and guide physicians as they make decisions related to heart transplants and left ventricular assist devices (pumps for patients who have reached end-stage heart failure). Future research will tackle the important task of heart failure and disease prediction, to facilitate earlier intervention for those most likely to experience heart failure, and preempt progression and damaging events. Ultimately this would also include informing the specific therapeutic decisions most likely to work for individuals.

“AI is poised to fundamentally transform outcomes in cardiovascular health care by providing doctors with better models for diagnosis and risk prediction in heart disease,” said Kavita Bala, professor of computer science and dean of Cornell Bowers CIS. “This unique collaboration between Cornell’s world-leading experts in machine learning and AI and outstanding cardiologists and clinicians from NewYork-Presbyterian, Weill Cornell Medicine and Columbia will drive this next wave of innovation for long-lasting impact on cardiovascular health care.”

“Artificial intelligence and technology are changing our society and the way we practice medicine,” said Dr. Nir Uriel, director of advanced heart failure and cardiac transplantation at NewYork-Presbyterian, an adjunct professor of medicine in the Greenberg Division of Cardiology at Weill Cornell Medicine and a professor of medicine in the Division of Cardiology at Columbia University Vagelos College of Physicians and Surgeons. “We look forward to building a bridge into the future of medicine, and using advanced technology to provide tools to enhance care for our heart failure patients.”

“Major algorithmic advances are needed to derive precise and reliable clinical insights from complex medical data,” said Deborah Estrin, the Robert V. Tishman ’37 Professor of Computer Science, associate dean for impact at Cornell Tech and a professor of population health science at Weill Cornell Medicine. “We are excited about the opportunity to partner with leading cardiologists to advance the state-of-the-art in caring for heart failure and other challenging cardiovascular conditions.”

Related Links:
Cornell University 

BMP Whole Blood Analyzer: GEM Premier ChemSTAT
Gold Supplier
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Hepatitis/HBcAb CLIA Test
Real-Time PCR System

Print article


Critical Care

view channel
Image: The genetically engineered FcMBL protein can capture more than 100 different microbial species (Photo courtesy of Wyss Institute)

Rapid Pathogen Capture Technology Could Accelerate Diagnosis of Bloodstream Infections and Sepsis

Bloodstream infections (BSIs) with various microbial pathogens can rapidly escalate to life-threatening sepsis when the body is overwhelmed by the multiplying invaders and shuts down its organs’ functions.... Read more

Surgical Techniques

view channel
Image: CystoSmart image enhancement and AI diagnostic tool will enhance cancer detection (Photo courtesy of Claritas HealthTech)

AI Diagnostic Tool Improves Cancer Detection in Cystoscope Images of Bladder

Bladder cancer is the 10th commonest cancer worldwide and the 6th commonest cancer amongst men. It is known to have high recurrence rates and significant risks of disease progression. Early detection of... Read more

Patient Care

view channel
Image: Automated cleaning system allows endoscopes to be cleaned direct from clinic (Photo courtesy of Aston University)

World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance

Endoscopes are long, thin tubes with a light and camera at one end. Due to the sensitivity of the materials and electronics they cannot be sterilized in an autoclave (a machine that uses steam under pressure),... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more


view channel
Image: The global multiparameter patient monitoring systems market is expected to surpass USD 15 billion by 2028 (Photo courtesy of Unsplash)

Global Multiparameter Patient Monitoring Systems Market Driven by Rising Chronic Illnesses

Multi-parameter patient monitoring equipment is used to assess the vital signs of patients who are suffering from a serious illness. These devices are meant to give the number of data sets on one screen... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.